In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hu, Zhenhua ^a,b   Qu, Yawei ^c   Wang, Kun ^a,b   Zhang, Xiaojun ^d   Zha, Jiali ^c   Song, Tianming ^a   Bao, Chengpeng ^a   Liu, Haixiao ^a   Wang, Zhongliang ^e   Wang, Jing ^f   Liu, Zhongyu ^g   Liu, Haifeng ^c   Tian, Jie ^a,b,h  

^a INSTITUTE OF AUTOMATION   (China)

^b Beijing National Laboratory of Molecular Sciences   (China)

^c GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e XIDIAN UNIVERSITY   (China)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^g No 150 Central Hospital of PLA   (China)

^h INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EUROPIUM; EUROPIUM OXIDE NANOPARTICLE; FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; NANOPARTICLE; OXIDE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ELECTROMAGNETIC RADIATION; EUROPIUM; IMAGING METHOD; LESION; NANOTECHNOLOGY; OPTICAL METHOD; RADIONUCLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERENKOV LUMINESCENCE IMAGING; CERENKOV RADIATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG MIXTURE; ELECTROMAGNETIC RADIATION; FEMALE; FLUORESCENCE IMAGING; GAMMA RADIATION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS; TUMOR DIAGNOSIS; TUMOR XENOGRAFT; ACOUSTIC MICROSCOPY; ANIMAL; NUDE MOUSE; PROCEDURES;

ANIMALS; EUROPIUM; FEMALE; MALE; MICE; MICE, NUDE; MICROSCOPY, ACOUSTIC; NANOPARTICLES; OPTICAL IMAGING; RADIOPHARMACEUTICALS;

EID: 84934755353     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8560     Document Type: Article

References (36)

1. Robertson, R. et al. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys. Med. Biol. 54, N355-N365 (2009).
2. Ruggiero, A., Holland, J. P., Lewis, J. S. & Grimm, J. Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med. 51, 1123-1130 (2010).
3. Xu, Y., Liu, H. & Cheng, Z. Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J. Nucl. Med. 52, 2009-2018 (2011).
4. Xu, Y. et al. Proof-of-concept study of monitoring cancer drug therapy with Cerenkov luminescence imaging. J. Nucl. Med. 53, 312-317 (2012).
5. Li, C., Mitchell, G. S. & Cherry, S. R. Cerenkov luminescence tomography for small-animal imaging. Opt. Lett. 35, 1109-1111 (2010).
6. Hu, Z. et al. Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation. Opt. Express 18, 24441-24450 (2010).
7. Robertson, R., Germanos, M. S., Manfredi, M. G., Smith, P. G. & Silva, M. D. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model. J. Nucl. Med. 52, 1764-1769 (2011).
8. Holland, J. P., Normand, G., Ruggiero, A., Lewis, J. S. & Grimm, J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Mol. Imaging 10, 177-186 (2011).
9. Hu, Z. et al. Cerenkov luminescence tomography of aminopeptidase N (APN/ CD13) expression in mice bearing HT1080 tumors. Mol. Imaging 12, 173-181 (2013).
10. Thorek, D. L. et al. Cerenkov imaging - A new modality for molecular imaging. Am. J. Nucl. Med. Mol. Imaging 2, 163-173 (2012).
11. Hu, Z. et al. Three-dimensional noninvasive monitoring iodine-131 uptake in the thyroid using a modified Cerenkov luminescence tomography approach. PLoS ONE 7, e37623 (2012).
12. Liu, H. et al. Optical imaging of reporter gene expression using a positronemission-tomography probe. J. Biomed. Opt. 15, 060505 (2010).
13. Mitchell, G. S., Gill, R. K., Boucher, D. L., Li, C. & Cherry, S. R. In vivo Cerenkov luminescence imaging: a new tool for molecular imaging. Philos. Trans. A Math. Phys. Eng. Sci. 369, 4605-4619 (2011).
14. Liu, H. et al. Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. J. Nucl. Med. 53, 1579-1584 (2012).
15. Liu, H. et al. Molecular optical imaging with radioactive probes. PLoS ONE 5, e9470 (2010).
16. Spinelli, A. E. et al. First human Cerenkography. J. Biomed. Opt. 18, 20502 (2013).
17. Thorek, D. L., Ried, C. C. & Grimm, J. Clinical Cerenkov luminescence imaging of (18)F-FDG. J. Nucl. Med. 55, 95-98 (2014).
18. Chin, P. T. et al. Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur. J. Nucl. Med. Mol. Imaging 40, 1283-1291 (2013).
19. Thorek, D. L., Ogirala, A., Beattie, B. J. & Grimm, J. Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat. Med. 19, 1345-1350 (2013).
20. Thorek, D. L., Das, S. & Grimm, J. Molecular imaging using nanoparticle quenchers of Cerenkov luminescence. Small 10, 3729-3734 (2014).
21. Dothager, R. S., Goiffon, R. J., Jackson, E., Harpstrite, S. & Piwnica-Worms, D. Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems. PLoS ONE 5, e13300 (2010).
22. Axelsson, J., Davis, S. C., Gladstone, D. J. & Pogue, B. W. Cerenkov emission induced by external beam radiation stimulates molecular fluorescence. Med. Phys. 38, 4127-4132 (2011).
23. Ma, X. et al. Enhancement of Cerenkov luminescence imaging by dual excitation of Er3+, Yb3+-doped rare-earth microparticles. PLoS ONE 8, e77926 (2013).
24. Zhuravleva, M., Friedrich, S. & Melcher, C. L. The europium oxidation state in CsSrI3:Eu scintillators measured by X-ray absorption spectroscopy. Opt. Mater. 36, 670-674 (2014).
25. Shen, J., Sun, L. D. & Yan, C. H. Luminescent rare earth nanomaterials for bioprobe applications. Dalton Trans. 24, 5687-5697 (2008).
26. Carpenter, C. M. et al. Radioluminescent nanophosphors enable multiplexed small-animal imaging. Opt. Express. 20, 11598-11604 (2012).
27. Sun, C. et al. Synthesis and radioluminescence of PEGylated Eu(3+)-doped nanophosphors as bioimaging probes. Adv. Mater. 23, H195-H199 (2011).
28. Chen, H. et al. Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence. ACS Nano 7, 1178-1187 (2013).
29. Bellevre, D. et al. Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? Eur. J. Nucl. Med. Mol. Imaging 41, 1103-1112 (2014).
30. Soret, M., Bacharach, S. L. & Buvat, I. Partial-volume effect in PET tumor imaging. J. Nucl. Med. 48, 932-945 (2007).
31. Hoetjes, N. J. et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur. J. Nucl. Med. Mol. Imaging 37, 1679-1687 (2010).
32. Bhaumik, S. & Gambhir, S. S. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl Acad. Sci. USA 99, 377-382 (2002).
33. So, M.K., Xu, C., Loening, A.M., Gambhir, S.S. & Rao, J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol. 24, 339-343 (2006).
34. Pratx, G., Carpenter, C. M., Sun, C., Rao, R. P. & Xing, L. Tomographic molecular imaging of x-ray-excitable nanoparticles. Opt. Lett. 35, 3345-3347 (2010).
35. Pratx, G., Carpenter, C. M., Sun, C. & Xing, L. X-ray luminescence computed tomography via selective excitation: a feasibility study. IEEE Trans. Med. Imaging 29, 1992-1999 (2010).
36. Cong, W. et al. Practical reconstruction method for bioluminescence tomography. Opt. Express. 13, 6756-6771 (2005).